Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
British Journal of Clinical Pharmacology|October 9, 2012
A pharmacologic perspective on newly emerging T-cell manipulation technologiesDominic SmethurstExpert Opinion on Pharmacotherapy|August 21, 2002
The pharmacoeconomic impact of generics: an evolutionary taleDominic SmethurstCancer Chemotherapy and Pharmacology|November 23, 2006
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteersD Ross Camidge, Dominic Smethurst, Jim Growcott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancerJean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancerEric Van Cutsem, Cathy Eng, Elzbieta Nowara, et al.Pageof 1